Tapewire

Nasdaq · USD

EDIT

Editas Medicine, Inc.

Export transactions ↓
Tapewire entity
5502
SEC CIK
0001650664
Parsed reports
306

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202600
Feb 202600
Mar 202603
Apr 202600
May 202600
Jun 202603
Jul 202601
Aug 202601
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 06, 2016 Filed Sep 7, 2016 16:05 UTC
STARR KEVIN P10% owner
SaleCommon Stock 5,890 $15.90 $93,665.73
Disclosure

SEC source: 0000899243-16-028604 · doc4.xml · nonDerivative · entry 1

STARR KEVIN P · CIK 0001192603 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Such shares were received as a distribution from Third Rock Ventures III, L.P. ("TRV III") on August 16, 2016 in a transaction exempt pursuant to Rule 16a-13 and Rule 16a-9.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.